Topinková Eva
Vnitr Lek. 2018 Winter;64(11):1038-1052.
Sarcopenia is defined as generalized and progressive age-related loss of skeletal muscle mass, muscle strength and physical performance below a defined threshold. In sarcopenia skeletal muscle mass - the largest body organ - is failing in its function and the term "muscle failure" was suggested. Sarcopeniat is now recognized as a serious clinical problem compromising healthy aging concept and quality of life of affected older people. Sarcopenia has a complex multifactorial pathogenesis, which involves not only age-related changes in neuromuscular function, muscle protein turnover, and hormone levels and sensitivity, but also a chronic pro-inflammatory state, oxidative stress, and behavioral factors - particularly nutritional status and degree of physical activity. The paper provides detailed review of screening and diagnostic methods and consensus-based cut off values and biomarkers of potential patophysiologic mechanisms involved in sarcopenia development in individual patient. Further, detailed description of current preventive and therapeutic strategies for sarcopenia is included. These involve structured physical activities, namely progressive resistance training and aerobic activities which prevent muscle loss and improve muscle performance. The effect of exercise is enhanced by nutritional supplementation, particularly through proteoanabolic effect of proteins and some amino acids. There are no currently registered drugs with indication of sarcopenia but there are promising substances in higher phases of clinical trials (such as antimyostatin human monoclonal antibodies, selective androgen receptor modulators) which have the potential to be introduced into clinical practice soon. Conclusions Sarcopenia is a new clinical diagnosis of organ failure of the skeletal muscle function leading to multiple adverse health outcomes. Physicians should be aware of clinical symptoms and diagnostic algorithm and target treatment according to sarcopenia leading causes. Key words: clinical diagnosis and treatment - muscle failure - muscle mass, strength and function - sarcopenia.
肌肉减少症的定义为,与年龄相关的全身性、渐进性骨骼肌质量、肌肉力量和身体机能丧失,且低于特定阈值。在肌肉减少症中,骨骼肌质量(人体最大的器官)功能衰退,因此有人提出了“肌肉衰竭”这一术语。如今,肌肉减少症被认为是一个严重的临床问题,它损害了健康老龄化的理念以及受影响老年人的生活质量。肌肉减少症具有复杂的多因素发病机制,这不仅涉及神经肌肉功能、肌肉蛋白质周转、激素水平及敏感性等与年龄相关的变化,还涉及慢性促炎状态、氧化应激和行为因素,尤其是营养状况和身体活动程度。本文详细综述了筛查和诊断方法、基于共识的临界值以及个体患者肌肉减少症发生过程中潜在病理生理机制的生物标志物。此外,还详细描述了目前针对肌肉减少症的预防和治疗策略。这些策略包括有组织的体育活动,即渐进性抗阻训练和有氧运动,它们可以防止肌肉流失并改善肌肉机能。营养补充,特别是通过蛋白质和某些氨基酸的促蛋白合成作用,可增强运动效果。目前尚无已注册用于治疗肌肉减少症的药物,但在临床试验更高阶段有一些有前景的物质(如抗肌生成抑制素人单克隆抗体、选择性雄激素受体调节剂),它们有可能很快被引入临床实践。结论 肌肉减少症是骨骼肌功能器官衰竭的一种新的临床诊断,会导致多种不良健康后果。医生应了解临床症状和诊断算法,并根据肌肉减少症的主要病因进行靶向治疗。关键词:临床诊断与治疗;肌肉衰竭;肌肉质量、力量和功能;肌肉减少症